(Q46239537)

20 December 2017

title

Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant (English)

1 reference

20 December 2017

0 references

Bacillus brevis

1 reference

Goto N

1

1 reference

20 December 2017

Maeyama J

2

1 reference

20 December 2017

Yasuda Y

3

1 reference

20 December 2017

Isaka M

4

1 reference

20 December 2017

Matano K

5

1 reference

20 December 2017

Kozuka S

6

1 reference

20 December 2017

Taniguchi T

7

1 reference

20 December 2017

Miura Y

8

1 reference

20 December 2017

Ohkuma K

9

1 reference

20 December 2017

Tochikubo K

10

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

20 December 2017

number of pages

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

20 December 2017

volume

18

1 reference

20 December 2017

issue

20

1 reference

20 December 2017

page(s)

2164-2171

1 reference

20 December 2017

Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Properties of homogeneous heat-labile enterotoxin from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Studies on the toxicities of aluminium hydroxide and calcium phosphate as immunological adjuvants for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

An enzyme-release assay for natural cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Intracellular lactate dehydrogenase concentration as an index of cytotoxicity in rat hepatocyte primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

A comparison of the NK cell cytotoxicity with effects of TNF-alpha against K-562 cells, determined by LDH release assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Nasal diagrams: a tool for recording the distribution of nasal lesions in rats and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Histopathology and cell replication responses in the respiratory tract of rats and mice exposed by inhalation to glutaraldehyde for up to 13 weeks

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Nasal Lesion Development and Reversibility in Rats Exposed to Aerosols of Dibasic Esters

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Cytotoxic and adaptive effects in rat nasal epithelium after 3-day and 13-week exposure to low concentrations of formaldehyde vapour

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Local histopathological reactions to aluminum-adsorbed tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

The binding of chimeric peptides to GM1 ganglioside enables induction of antibody responses after intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

A Permeability Factor (Toxin) Found in Cholera Stools and Culture Filtrates and its Neutralization by Convalescent Cholera Sera

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900337-0

7 January 2021

10.1016/S0264-410X(99)00337-0

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

10715532

1 reference

20 December 2017